TRASTUZUMAB (150 MG) – A Comprehensive Guide
Trastuzumab is a potent medication used in the treatment of various cancers. It is manufactured by Biocon Pharma and falls under the category of Uncategorised medicines. Trastuzumab is available in the form of an injection with each vial containing 150 mg of the active ingredient.
Active Ingredients
The active ingredient in Trastuzumab is trastuzumab itself, which is a monoclonal antibody that targets specific proteins in cancer cells.
Pharmacological Properties
Trastuzumab works by binding to the HER2 receptors present on cancer cells, thereby inhibiting the growth and spread of these cells. This targeted approach makes it an effective treatment option for HER2-positive cancers.
Indications
Trastuzumab is indicated for the treatment of:
- Breast cancer
- Gastric cancer
Contraindications
Trastuzumab is contraindicated in individuals with a known hypersensitivity to the drug or any of its components. It should not be used in patients with pre-existing heart conditions.
Dosage
The dosage of Trastuzumab may vary depending on the type and stage of cancer being treated. It is typically administered intravenously by a healthcare professional at the prescribed dose and frequency.
Side Effects
Common side effects of Trastuzumab may include:
- Nausea
- Fatigue
- Diarrhea
- Infusion reactions
It is important to report any unusual or severe side effects to your healthcare provider.
Drug Interactions
Trastuzumab may interact with certain medications, including other chemotherapeutic agents or drugs that affect heart function. It is essential to inform your healthcare provider about all the medications you are taking before starting Trastuzumab treatment.
Patient Counseling
Patient counseling is crucial for individuals undergoing Trastuzumab therapy. Patients should be informed about the treatment process, possible side effects, and the importance of regular monitoring during the course of treatment.
Clinical Evidence
Several clinical studies have demonstrated the efficacy and safety of Trastuzumab in treating HER2-positive cancers. The drug has shown significant improvements in patient outcomes and survival rates, making it a valuable therapeutic option in oncology.
Frequently Asked Questions (FAQs)
Q: How does Trastuzumab work?
A: Trastuzumab works by targeting and binding to HER2 receptors on cancer cells, reducing their growth and spread.
Q: What are the common side effects of Trastuzumab?
A: Common side effects of Trastuzumab include nausea, fatigue, diarrhea, and infusion reactions.
Q: Can Trastuzumab be used in all types of cancer?
A: Trastuzumab is specifically indicated for HER2-positive breast and gastric cancers and should only be used under healthcare provider supervision.
Q: What should I do if I experience severe side effects while on Trastuzumab?
A: If you experience severe side effects or any allergic reactions, contact your healthcare provider immediately for further guidance.
Q: How should Trastuzumab be stored?
A: Trastuzumab should be stored as per the manufacturer’s recommendations, typically at controlled room temperature away from moisture and sunlight.
Overall, Trastuzumab is a crucial medication in the treatment of HER2-positive cancers, offering significant benefits to patients when used appropriately and under medical supervision.
